Sunepitron
Sign in to saveSunepitron (developmental code name CP-93,393) is a combined 5-HT1A receptor agonist and α2-adrenergic receptor antagonist. It was previously under development by Pfizer for the treatment of depression and anxiety. It made it to phase III clinical trials before being discontinued.
Wikidata facts
- Mass
- 329.185175
Show 2 more facts
- chemical formula
- C₁₇H₂₃N₅O₂
- canonical SMILES
- C1CC2CN(CCN2CC1CN3C(=O)CCC3=O)C4=NC=CC=N4
Sources (1)
via Wikidata · CC0
~2 min read
Article
4 sectionsContents
- Chemistry
- Synthesis
- See also
- References
{{Drugbox | IUPAC_name = 1-{[2-(pyrimidin-2-yl)octahydro-2H-pyrido[1,2-a]pyrazin-7-yl]methyl}pyrrolidine-2,5-dione | image = Sunepitron.png | image_class = skin-invert-image | width =
| tradename = | pregnancy_category = | legal_status = | routes_of_administration = Oral
Connections
propranolol
Entity
N-methylserotonin
Entity
atenolol
Entity
tricyclic antidepressant
Entity
monoamine oxidase inhibitor
Entity
adrenergic receptor
Entity
serotonin–norepinephrine reuptake inhibitor
Entity
labetalol
Entity
ergoline
Entity
levobunolol
Entity
tetracyclic antidepressant
Entity
glaucine
Entity
5-carboxamidotryptamine
Entity
azasetron
Entity
Serotonin antagonist and reuptake inhibitor
Entity
5-methoxytryptamine
Entity
tryptamines
Entity
α-methyl-5-HT
Entity
exaprolol
Entity
International Standard Book Number
Entity